drugset / Trial / NCT01006252
A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study was to see how tasisulam-sodium affected metastatic melanoma when compared against paclitaxel as measured by overall survival.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |
| Subject | Tasisulam | Small molecule | — | Intravenous |